
Our Q4 newsletter
Welcome to the latest FLF newsletter We hope this newsletter finds you well and that you enjoyed the holidays. We’d like to share some of
Welcome to the latest FLF newsletter We hope this newsletter finds you well and that you enjoyed the holidays. We’d like to share some of
ASH Annual Meeting 2022 – summary and key take-outs By Dr Zoe Drymoussi During the 9-12th December 2022, the FLF team attended, in person, for
Looking back over the last 25 years for FL – the Rituximab era By Dr Mitchell Smith, Chief Medical Officer A recent re-publication marking 25
Research in focus: Bi-specific antibodies approval. By Dr. Zoe Drymoussi Over the last few years, a promising new class of treatments for advanced-stage FL has
FLF are attending the ASH 2022 Annual Meeting We are delighted that some of the team are able to attend the 64th ASH Annual Meeting
New funding of $2 million for research to get one step closer to a cure for Follicular Lymphoma. Our mission at the FLF is to
Welcome to the latest FLF newsletter Thank-you so much for your continued support on our mission. We would not be able to make the impact
Henry and Esther Shirman, two supporters that have been with the FLF since day one, recently celebrated their 50th wedding anniversary, and they certainly did
The wonderful Snowdown Colliery Welfare Brass Band recently (October 8th) created a fabulous afternoon of music for the local community of Dover, Kent. The band
Kate Rogers joins from her previous role at GSK plc as Global Finance Transformation Lead at GSK. She also continues to serves as Non-Executive Director